Benjamin OAKES — 11 Patents at Scribe Therapeutics

Benjamin OAKES has been granted 11 US patents while listed as an inventor at Scribe Therapeutics. The first was granted in 2018 and the most recent in April 2025. Benjamin OAKES ranks #435,149 of 4,157,543 US inventors in our database (top 10.5%). Patent records list Benjamin OAKES in El Cerrito, CA, US.

Patents per Year

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #	Title	Co-Inventors	Date
12275964	Variant type V CRISPR/Cas effector polypeptides and methods of use thereof	Jennifer A. Doudna, Natalia Orlova, Junjie Liu	2025-04-15
12163125	Engineered class 2 type V CRISPR systems	Gayathri VIJAYAKUMAR, Sean HIGGINS, Isabel COLIN, Sarah DENNY, Brett T. STAAHL +2 more	2024-12-10
12084692	Guide scaffolds	Sean HIGGINS, Hannah SPINNER, Sarah DENNY, Brett T. STAAHL, Kian TAYLOR +3 more	2024-09-10
11976277	Particle delivery systems	Jason FERNANDES, Sean HIGGINS, Isabel COLIN, Hannah SPINNER, Matthew Gardner +7 more	2024-05-07
11613742	Compositions and methods for the targeting of SOD1	Sean HIGGINS, Hannah SPINNER, Sarah DENNY, Brett T. STAAHL, Kian TAYLOR +4 more	2023-03-28
11560555	Engineered proteins	Sean HIGGINS, Hannah SPINNER, Sarah DENNY, Brett T. STAAHL, Kian TAYLOR +3 more	2023-01-24
11535835	Compositions and methods for the targeting of rhodopsin	Hannah SPINNER, Sarah DENNY, Brett T. STAAHL, Kian TAYLOR, Katherine BANEY +4 more	2022-12-27
11180778	Variant RNA-guided polypeptides and methods of use	David Savage, Jennifer A. Doudna, Rayka Yokoo	2021-11-23
11008555	Variant Cas9 polypeptides comprising internal insertions	David Savage, Dana Nadler, Abraham I. Flamholz, Jennifer A. Doudna	2021-05-18
10494620	Methods and compositions for modifying a single stranded target nucleic acid	Jennifer A. Doudna, Samuel Henry Sternberg, Mitchell Ray O'Connell	2019-12-03
9994831	Methods and compositions for modifying a single stranded target nucleic acid	Jennifer A. Doudna, Samuel Henry Sternberg, Mitchell Ray O'Connell	2018-06-12